What are the newest statin drugs?

What are the newest statin drugs?

Another newer option is actually a statin. It’s called pitavastatin, or Livalo. It has the same LDL- and total cholesterol-lowering property as all the other statins, but somehow doesn’t give the muscle aches. A lot of people have had a lot of success taking this over any of the other statins out there.

What is the drug of choice for hyperlipidemia?

Statins are the most commonly prescribed lipid-lowering agents because they are effective, well tolerated and easy to administer. Niacin has beneficial effects on all of the main lipid components, and new extended-release tablets have fewer adverse effects.

What is the first drug of choice for hyperlipidemia?

To date, statins remain the first-choice therapy, as they have been shown to reduce the risk of major vascular events by lowering low-density lipoprotein cholesterol (LDL-C).

What drug can replace atorvastatin?

Other alternatives to atorvastatin.

  • Other HMG CoA Reductase Inhibitors (statins) such as: Crestor (rosuvastatin), Zocor (simvastatin), Pravachol (pravastatin), or Mevachor (lovastatin)
  • Colestid (colestipol)
  • Tricor (fenofibrate)
  • Zetia (ezetimibe)
  • WelChol (colesevelam)
  • Is there a better statin than atorvastatin?

    This study compiled results from 50 randomized, clinical trials, and compared other statin drugs like fluvastatin, pravastatin, rosuvastatin, and lovastatin. Rosuvastatin had the highest potency for lowering LDL levels in the study.

    Is there a non statin cholesterol medication?

    Ezetimibe (Zetia) It’s one of the few non-statin drugs that can lower LDL cholesterol levels even more when added on top of statin. And, it’s the only drug that, when combined with a statin, further lowers the risk of cardiovascular disease.

    What are the new drugs for dyslipidaemia?

    New drugs for dyslipidaemia have emerged: some have already been approved by drug agencies and others are still being evaluated. Bempedoic acid, an ATP citrate lyase [1], modulates cholesterol synthesis and LDL-C level. The results of a CV outcomes study are awaited.

    What drugs lower LDL cholesterol by more than 50%?

    Three years ago, the FDA approved two drugs that lower harmful LDL cholesterol values dramatically — by more than 50%. The drugs, alirocumab (Praluent) and evolocumab (Repatha), belong to a new category of medications known as PCSK9 inhibitors.

    What are the treatment options for hyperlipidemia?

    New and novel treatments for hyperlipidemia. Oct. 03, 2020. Statin drugs are very effective in reducing levels of low-density lipoprotein (LDL) cholesterol, one of the causal agents in the development of atherosclerotic disease. Statins lower cholesterol by inhibition of HMG-CoA reductase, the rate-limiting step in the synthesis of cholesterol.

    Are PCSK9 inhibitors the best way to lower cholesterol?

    For people at high risk, PCSK9 inhibitors may prevent heart attacks and save lives. But gaining access to these pricey drugs remains a challenge. Three years ago, the FDA approved two drugs that lower harmful LDL cholesterol values dramatically — by more than 50%.